What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Message Boards Settings Cambridge Heart Inc. - Quote Info
Microvolt T-Wave Alternans - Medcompare     15-Aug-08 12:38 pm    
Mintu Turakhia, M.D.
Division of Cardiology & Cardiac Electrophysiology
University of California, San Francisco School of Medicine

"In conclusion, there is now a large body of evidence to support the added prognostic value, clinical benefit, and cost-effectiveness of MTWA testing. A negative MTWA offers strong negative predictive value in assuring a 3% or less risk of SCD. CMS has come forth strongly in favor of use of the technology and reimbursement and a handful of private insurance companies have followed suit. Whether MTWA testing will someday be mandatory remains to be seen, but the technology is clearly here to stay."

http://www.medcompare.com/spotlight.asp?...
Rating :
 (2 Ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

FortuneKing


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
Microvolt T-Wave Alternans - Medcompare
FortuneKing (2 Ratings) 15-Aug-08 12:38 pm  
 
Yeah, but he's preaching to the choir. If the fiel...
wiech89 15-Aug-08 07:29 pm  
 
05 Mar 2009 "The results demonstrate that...
FortuneKing Rate it 18-Mar-09 01:10 am  
 
"...large body of evidence..."
FortuneKing Rate it 6-Nov-09 01:18 pm  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Cambridge Heart Inc. (CAMH.OB)

Chart for Cambridge Heart Inc. (CAMH.OB)
On Nov 30: 0.073 0.00 (0.00%)
Symbol Lookup